1. Home
  2. BLBD vs ANIP Comparison

BLBD vs ANIP Comparison

Compare BLBD & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$70.65

Market Cap

2.3B

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$79.97

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
ANIP
Founded
1927
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2013
1999

Fundamental Metrics

Financial Performance
Metric
BLBD
ANIP
Price
$70.65
$79.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$68.00
$110.00
AVG Volume (30 Days)
408.8K
244.0K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
22.78
419.23
EPS
1.84
1.28
Revenue
$1,480,099,000.00
$206,547,000.00
Revenue This Year
$5.87
$21.01
Revenue Next Year
$6.83
$17.59
P/E Ratio
$41.33
$61.23
Revenue Growth
9.87
2.47
52 Week Low
$42.95
$62.61
52 Week High
$83.39
$99.50

Technical Indicators

Market Signals
Indicator
BLBD
ANIP
Relative Strength Index (RSI) 39.51 48.73
Support Level $60.73 $79.69
Resistance Level $73.75 $83.66
Average True Range (ATR) 2.82 2.39
MACD -0.81 -0.32
Stochastic Oscillator 16.52 39.84

Price Performance

Historical Comparison
BLBD
ANIP

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: